Effects of antithyroid drug therapy on bone mineral density of young women with endogenous subclinical hyperthyroidism
Phase 2
- Conditions
- Subclinical hyperthyroidism.Thyrotoxicosis, unspecified Hyperthyroidism NOS
- Registration Number
- IRCT138809012750N1
- Lead Sponsor
- Kurdistan university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Young women referred to Kurdistan nuclear medicine center for thyroid evaluation which has suppressed TSH and normal FT4 and FT3 without history of thyroid disorders.
Exclusion criteria: Secondary osteoporosis, hypersensitivity to oral anti-thyroid drugs, discontinuation of 1 year follow-up
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thyroid function. Timepoint: 3-6-12 months after treatment. Method of measurement: TSH, freeT3, freeT4 measurement by IRMA & RIA methods.
- Secondary Outcome Measures
Name Time Method Bone mineral density. Timepoint: 12 months after treatment or follow-up. Method of measurement: Measuring BMD of lumbar vertebrae(L2-L4) and femoral neck by DXA method.